Published in J Endourol on March 01, 2009
Soda and other beverages and the risk of kidney stones. Clin J Am Soc Nephrol (2013) 1.82
Epidemiology of stone disease across the world. World J Urol (2017) 0.92
Dietary therapy for patients with hypocitraturic nephrolithiasis. Nat Rev Urol (2011) 0.88
Histological effects of chronic consumption of soda pop drinks on kidney of adult Wister rats. N Am J Med Sci (2010) 0.83
Effect of diet orange soda on urinary lithogenicity. Urol Res (2011) 0.82
Cola beverage and delayed elimination of methotrexate. Br J Clin Pharmacol (2010) 0.81
Preventive fluid and dietary therapy for urolithiasis: An appraisal of strength, controversies and lacunae of current literature. Indian J Urol (2011) 0.81
Chronic effects of soft drink consumption on the health state of Wistar rats: A biochemical, genetic and histopathological study. Mol Med Rep (2016) 0.77
A prospective study of dietary calcium and other nutrients and the risk of symptomatic kidney stones. N Engl J Med (1993) 5.87
Urinary volume, water and recurrences in idiopathic calcium nephrolithiasis: a 5-year randomized prospective study. J Urol (1996) 3.42
Dietary factors and the risk of incident kidney stones in men: new insights after 14 years of follow-up. J Am Soc Nephrol (2004) 2.60
Beverage use and risk for kidney stones in women. Ann Intern Med (1998) 2.32
Low urine pH: a novel feature of the metabolic syndrome. Clin J Am Soc Nephrol (2007) 2.02
Prospective study of beverage use and the risk of kidney stones. Am J Epidemiol (1996) 1.83
Glyoxylate synthesis, and its modulation and influence on oxalate synthesis. J Urol (1998) 1.70
Studies on the mechanism of fructose-induced hyperuricemia in man. Metabolism (1972) 1.67
Estimation of the oxalate content of foods and daily oxalate intake. Kidney Int (2000) 1.62
Fructose-induced in vivo insulin resistance and elevated plasma triglyceride levels in rats. Am J Clin Nutr (1989) 1.60
Acute caffeine effects on urine composition and calcium kidney stone risk in calcium stone formers. J Urol (2004) 1.51
Metabolic syndrome and uric acid nephrolithiasis. Semin Nephrol (2008) 1.36
Aspects on estimation of the risk of calcium oxalate crystallization in urine. Urol Int (1991) 1.32
Novel insights into the pathogenesis of uric acid nephrolithiasis. Curr Opin Nephrol Hypertens (2004) 1.20
Relationship of protein intake to urinary oxalate and glycolate excretion. Kidney Int (1993) 1.16
Effect of orange juice consumption on urinary stone risk factors. J Urol (1993) 1.16
Dietary manipulation with lemonade to treat hypocitraturic calcium nephrolithiasis. J Urol (1996) 1.15
Comparative value of orange juice versus lemonade in reducing stone-forming risk. Clin J Am Soc Nephrol (2006) 1.10
Lemonade therapy increases urinary citrate and urine volumes in patients with recurrent calcium oxalate stone formation. Urology (2007) 1.08
A prospective study of renal stone recurrences. Br J Urol (1984) 1.07
The production of (14C) oxalate during the metabolism of (14C) carbohydrates in isolated rat hepatocytes. Aust J Exp Biol Med Sci (1980) 0.98
Quantitative assessment of citric acid in lemon juice, lime juice, and commercially-available fruit juice products. J Endourol (2008) 0.98
Long-term lemonade based dietary manipulation in patients with hypocitraturic nephrolithiasis. J Urol (2007) 0.98
Sugars, insulin sensitivity, and the postprandial state. Am J Clin Nutr (2003) 0.96
Comparison between lemonade and potassium citrate and impact on urine pH and 24-hour urine parameters in patients with kidney stone formation. Urology (2007) 0.96
The interaction between dietary fructose and magnesium adversely affects macromineral homeostasis in men. J Am Coll Nutr (2000) 0.96
Effect of cola consumption on urinary biochemical and physicochemical risk factors associated with calcium oxalate urolithiasis. Urol Res (1999) 0.95
Increase in urinary calcium and oxalate after fructose infusion. Horm Metab Res (1995) 0.94
Influence of grapefruit-, orange- and apple-juice consumption on urinary variables and risk of crystallization. Br J Nutr (2003) 0.90
Changes in urinary magnesium, citrate, and oxalate levels due to cola consumption. Urology (1992) 0.86
Hepatic oxalate production: the role of hydroxypyruvate. Biochem Med Metab Biol (1986) 0.81
Nutrition and urolithiasis. N Engl J Med (1978) 0.79
Fructose precipitates calcium phosphate in the kidneys of female rats fed magnesium-deficient diets. Magnes Res (1992) 0.78
Dietary fructose as compared to glucose and starch increases the calcium content of kidney of magnesium-deficient rats. J Nutr (1989) 0.77
Chapter 1: AUA guideline on management of staghorn calculi: diagnosis and treatment recommendations. J Urol (2005) 4.69
2007 guideline for the management of ureteral calculi. J Urol (2007) 4.44
2007 Guideline for the management of ureteral calculi. Eur Urol (2007) 3.98
Kidney stones: a global picture of prevalence, incidence, and associated risk factors. Rev Urol (2010) 3.62
Percutaneous management of calculi within horseshoe kidneys. J Urol (2003) 2.04
Co-Occurrence of Substance-Related and Other Mental Health Disorders Among Adolescent Cannabis Users. J Addict Med (2015) 2.03
Clinical effectiveness protocols for imaging in the management of ureteral calculous disease: AUA technology assessment. J Urol (2012) 1.94
Endothelial epsin deficiency decreases tumor growth by enhancing VEGF signaling. J Clin Invest (2012) 1.87
Dietary oxalate loads and renal oxalate handling. J Urol (2005) 1.81
Effect of exercise intensity on abdominal fat loss during calorie restriction in overweight and obese postmenopausal women: a randomized, controlled trial. Am J Clin Nutr (2009) 1.77
Impact of sodium-hydrogen exchange inhibition by cariporide on death or myocardial infarction in high-risk CABG surgery patients: results of the CABG surgery cohort of the GUARDIAN study. J Thorac Cardiovasc Surg (2003) 1.64
The impact of dietary calcium and oxalate ratios on stone risk. Urology (2012) 1.60
Overexpression of methyl-CpG binding protein 2 impairs T(H)1 responses. Sci Transl Med (2012) 1.56
Oxalobacter formigenes and its potential role in human health. Appl Environ Microbiol (2002) 1.49
Hydroxyproline metabolism in mouse models of primary hyperoxaluria. Am J Physiol Renal Physiol (2011) 1.49
Glyoxylate reductase activity in blood mononuclear cells and the diagnosis of primary hyperoxaluria type 2. Nephrol Dial Transplant (2006) 1.44
Glycolate and glyoxylate metabolism in HepG2 cells. Am J Physiol Cell Physiol (2004) 1.38
Re: Randomized and double-blinded clinical trial of the safety and calcium kidney stone dissolving efficacy of Lapis judaicus. J Urol (2014) 1.38
Changing indications of open stone surgery. Urology (2002) 1.34
The increased incidence of pure red cell aplasia with an Eprex formulation in uncoated rubber stopper syringes. Kidney Int (2005) 1.31
The impact of dietary oxalate on kidney stone formation. Urol Res (2004) 1.30
Sensitivity of human strains of Oxalobacter formigenes to commonly prescribed antibiotics. Urology (2012) 1.29
Uric Acid nephrolithiasis: recent progress and future directions. Rev Urol (2007) 1.23
Pepsin and carbonic anhydrase isoenzyme III as diagnostic markers for laryngopharyngeal reflux disease. Laryngoscope (2004) 1.23
Prevalence of hyperoxaluria after bariatric surgery. J Urol (2008) 1.22
Sodium-hydrogen exchange inhibition by cariporide to reduce the risk of ischemic cardiac events in patients undergoing coronary artery bypass grafting: results of the EXPEDITION study. Ann Thorac Surg (2008) 1.21
Impact of dietary calcium and oxalate, and Oxalobacter formigenes colonization on urinary oxalate excretion. J Urol (2011) 1.16
Epoetin-associated pure red cell aplasia in patients with chronic kidney disease: solving the mystery. Nephrol Dial Transplant (2005) 1.16
Computerized tomography guided access for percutaneous nephrostolithotomy. J Urol (2003) 1.12
Accuracy of urinary dipstick testing for pH manipulation therapy. J Endourol (2008) 1.10
Hypocitraturia: pathophysiology and medical management. Rev Urol (2009) 1.10
Oral antibiotic treatment of Helicobacter pylori leads to persistently reduced intestinal colonization rates with Oxalobacter formigenes. J Endourol (2011) 1.09
Increased protein intake on controlled oxalate diets does not increase urinary oxalate excretion. Urol Res (2009) 1.09
Metabolic syndrome and urologic diseases. Rev Urol (2010) 1.09
The genetic composition of Oxalobacter formigenes and its relationship to colonization and calcium oxalate stone disease. Urolithiasis (2013) 1.08
Ureteroscopic management of renal calculi in anomalous kidneys. Urology (2005) 1.08
Inner-city asthma: the role of the community. Chest (2007) 1.08
Aspirin and Tranexamic Acid for Coronary Artery Surgery (ATACAS) Trial: rationale and design. Am Heart J (2007) 1.06
Prostate abscess following intravesical bacillus Calmette-Guerin treatment. J Urol (2002) 1.06
Off-Pump versus Conventional Coronary Artery Bypass Grafting: A Meta-Analysis and Consensus Statement From The 2004 ISMICS Consensus Conference. Innovations (Phila) (2005) 1.06
Mitochondrial hydroxyproline metabolism: implications for primary hyperoxaluria. Am J Nephrol (2005) 1.04
Metabolism of [13C5]hydroxyproline in vitro and in vivo: implications for primary hyperoxaluria. Am J Physiol Gastrointest Liver Physiol (2011) 1.03
New generation tissue sealants and hemostatic agents: innovative urologic applications. Rev Urol (2006) 1.02
Active site and loop 4 movements within human glycolate oxidase: implications for substrate specificity and drug design. Biochemistry (2008) 1.01
Clinical trials of the surgical management of urolithiasis: current status and future needs. Adv Chronic Kidney Dis (2009) 1.00
Structural and biochemical studies of human 4-hydroxy-2-oxoglutarate aldolase: implications for hydroxyproline metabolism in primary hyperoxaluria. PLoS One (2011) 1.00
The effect of restrictive bariatric surgery on urinary stone risk factors. Urology (2010) 0.99
Glyoxal formation and its role in endogenous oxalate synthesis. Adv Urol (2012) 0.99
Quantitative assessment of citric acid in lemon juice, lime juice, and commercially-available fruit juice products. J Endourol (2008) 0.98
Role of laparoscopic stone surgery. Urology (2008) 0.98
Continuity of care is good for elderly people with diabetes: retrospective cohort study of mortality and hospitalization. Can Fam Physician (2011) 0.97
Drug-induced urinary calculi. Rev Urol (2003) 0.97
Continuity of care for older patients in family practice: how important is it? Can Fam Physician (2006) 0.96
Impact of stone removal on renal function: a review. Rev Urol (2011) 0.94
4-Hydroxy-2-oxoglutarate aldolase inactivity in primary hyperoxaluria type 3 and glyoxylate reductase inhibition. Biochim Biophys Acta (2012) 0.94
Xanthine urolithiasis. Urology (2006) 0.93
Metabolism of primed, constant infusions of [1,2-¹³C₂] glycine and [1-¹³C₁] phenylalanine to urinary oxalate. Metabolism (2010) 0.91
Variability of Oxalobacter formigenes and oxalate in stool samples. J Urol (2007) 0.90
Action of reactive oxygen species on colonic mucus secretions. Free Radic Biol Med (2007) 0.90
Lean mass loss is associated with low protein intake during dietary-induced weight loss in postmenopausal women. J Am Diet Assoc (2008) 0.89
Utility of frozen section analysis of resection margins during partial nephrectomy. Urology (2004) 0.89
Ileal ureter substitution: a contemporary series. Urology (2003) 0.88
Ureterocalicostomy: a contemporary experience. Urology (2005) 0.87
Optimizing shock wave lithotripsy: a comprehensive review. Rev Urol (2013) 0.86
Best of the 2007 AUA Annual Meeting: Highlights from the 2007 Annual Meeting of the American Urological Association, May 19-24, 2007, Anaheim, CA. Rev Urol (2007) 0.84
The treatment of lower pole renal calculi in 2003. Rev Urol (2002) 0.83
The association of cardiovascular disease and metabolic syndrome with nephrolithiasis. Curr Opin Urol (2012) 0.83
Nephrolithiasis in identical twins: the impact of nature vs nurture. BJU Int (2007) 0.83
Re: metabolic disturbances and renal stone promotion on treatment with topiramate: a systematic review. J Urol (2014) 0.83
Selecting Treatment for Distal Ureteral Calculi: Shock Wave Lithotripsy versus Ureteroscopy. Rev Urol (2003) 0.82
Transitional cell carcinoma within a calyceal diverticulum associated with stone disease. Rev Urol (2010) 0.82
Is the Internet a reliable source for dietary recommendations for stone formers? J Endourol (2009) 0.82
Percutaneous nephrostolithotomy: predictors of length of stay. J Urol (2004) 0.82
Behavioural and substance use problems in rural and urban delinquent youths. Can J Psychiatry (2003) 0.81
Hypercalcemic States associated with nephrolithiasis. Rev Urol (2008) 0.81
Adjunctive therapy to promote stone passage. Rev Urol (2005) 0.81
Management of cystinuria. Urol Clin North Am (2007) 0.80
Genetic and dietary factors in urinary citrate excretion. J Endourol (2005) 0.80
Intestinal and renal handling of oxalate loads in normal individuals and stone formers. Urol Res (2007) 0.80